Search research articles
Contact Us
Filters
Showing results (161-170 of 359) with videos related to
Page
of 36
Sort By:
Journal of Medicinal Chemistry
|
September 1, 2017
Exploring Structural Parameters for Pretargeting Radioligand Optimization
Jan-Philip Meyer, Paul Kozlowski, James Jackson, et al.
Molecular Pharmaceutics
|
August 20, 2015
Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics
Brian M Zeglis, Christian Brand, Dalya Abdel-Atti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 20, 2018
A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer
Kelly E Henry, Megan M Dacek, Thomas R Dilling, et al.
Bioconjugate Chemistry
|
March 24, 2007
Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14)
Gráinne B Biddlecombe, Buck E Rogers, Monique de Visser, et al.
Theranostics
|
December 8, 2016
A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer
Pierre Adumeau, Kathryn E Carnazza, Christian Brand, et al.
ACS Pharmacology & Translational Science
|
September 19, 2025
Correction to: "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy Against Human Epidermal Growth Factor Receptor 2‑Positive Breast Cancer Mouse Model"
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
ACS Pharmacology & Translational Science
|
December 14, 2023
Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 19, 2017
Long-Half-Life <sup>89</sup>Zr-Labeled Radiotracers Can Guide Percutaneous Biopsy Within the PET/CT Suite Without Reinjection of Radiotracer
Francois H Cornelis, Jeremy C Durack, Neeta Pandit-Taskar, et al.
Frontiers in Oncology
|
June 6, 2022
PET Imaging of Acidic Tumor Environment With <sup>89</sup>Zr-labeled pHLIP Probes
David Bauer, Hannah Visca, Anuradha Weerakkody, et al.
Journal of the American Chemical Society
|
August 2, 2013
H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy
Eric W Price, Brian M Zeglis, Jacqueline F Cawthray, et al.
Page
of 36
Search research articles
Search
Showing results (161-170 of 359) with videos related to
Sort By:
Page
of 36
Journal of Medicinal Chemistry
|
September 1, 2017
Exploring Structural Parameters for Pretargeting Radioligand Optimization
Jan-Philip Meyer, Paul Kozlowski, James Jackson, et al.
Molecular Pharmaceutics
|
August 20, 2015
Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics
Brian M Zeglis, Christian Brand, Dalya Abdel-Atti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 20, 2018
A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer
Kelly E Henry, Megan M Dacek, Thomas R Dilling, et al.
Bioconjugate Chemistry
|
March 24, 2007
Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14)
Gráinne B Biddlecombe, Buck E Rogers, Monique de Visser, et al.
Theranostics
|
December 8, 2016
A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer
Pierre Adumeau, Kathryn E Carnazza, Christian Brand, et al.
ACS Pharmacology & Translational Science
|
September 19, 2025
Correction to: "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy Against Human Epidermal Growth Factor Receptor 2‑Positive Breast Cancer Mouse Model"
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
ACS Pharmacology & Translational Science
|
December 14, 2023
Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model
Afruja Ahad, Hiwa K Saeed, Virginia Del Solar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 19, 2017
Long-Half-Life <sup>89</sup>Zr-Labeled Radiotracers Can Guide Percutaneous Biopsy Within the PET/CT Suite Without Reinjection of Radiotracer
Francois H Cornelis, Jeremy C Durack, Neeta Pandit-Taskar, et al.
Frontiers in Oncology
|
June 6, 2022
PET Imaging of Acidic Tumor Environment With <sup>89</sup>Zr-labeled pHLIP Probes
David Bauer, Hannah Visca, Anuradha Weerakkody, et al.
Journal of the American Chemical Society
|
August 2, 2013
H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy
Eric W Price, Brian M Zeglis, Jacqueline F Cawthray, et al.
Page
of 36